10-87930997-TCCTAA-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP6_Moderate
The NM_000314.8(PTEN):c.210-48_210-44delCCTAA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000055 in 1,455,674 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.0000046   (  0   hom.  ) 
Consequence
 PTEN
NM_000314.8 intron
NM_000314.8 intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  0.130  
Publications
0 publications found 
Genes affected
 PTEN  (HGNC:9588):  (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015] 
PTEN Gene-Disease associations (from GenCC):
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
BP6
Variant 10-87930997-TCCTAA-T is Benign according to our data. Variant chr10-87930997-TCCTAA-T is described in ClinVar as Benign. ClinVar VariationId is 255813.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8 | c.210-48_210-44delCCTAA | intron_variant | Intron 3 of 8 | ENST00000371953.8 | NP_000305.3 | ||
| PTEN | NM_001304717.5 | c.729-48_729-44delCCTAA | intron_variant | Intron 4 of 9 | NP_001291646.4 | |||
| PTEN | NM_001304718.2 | c.-541-48_-541-44delCCTAA | intron_variant | Intron 2 of 8 | NP_001291647.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000132  AC: 2AN: 151746Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
151746
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00000841  AC: 2AN: 237908 AF XY:  0.00000777   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
2
AN: 
237908
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000460  AC: 6AN: 1303928Hom.:  0   AF XY:  0.00000305  AC XY: 2AN XY: 655784 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
6
AN: 
1303928
Hom.: 
 AF XY: 
AC XY: 
2
AN XY: 
655784
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
30052
American (AMR) 
 AF: 
AC: 
0
AN: 
43594
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
24908
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
38484
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
82110
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52478
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5356
European-Non Finnish (NFE) 
 AF: 
AC: 
6
AN: 
972074
Other (OTH) 
 AF: 
AC: 
0
AN: 
54872
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.467 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000132  AC: 2AN: 151746Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74112 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
151746
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
74112
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41414
American (AMR) 
 AF: 
AC: 
0
AN: 
15194
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3464
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5200
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10618
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
67712
Other (OTH) 
 AF: 
AC: 
0
AN: 
2086
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.